Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “TAM”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00038103
What this trial is testing

Open-Label Study Of Exemestane With Or Without Celecoxib In Postmenopausal Women With ABC Having Progressed On Tamoxifen

Who this might be right for
Breast Neoplasms
Pfizer 111
Testing effectiveness (Phase 2)Study completedNCT02993159
What this trial is testing

Testing an Active Form of Tamoxifen (4-hydroxytamoxifen) Delivered Through Breast Skin to Control Ductal Carcinoma in Situ (DCIS) of the Breast

Who this might be right for
Ductal Breast Carcinoma In SituEstrogen Receptor Positive
Northwestern University 100
Early research (Phase 1)Study completedNCT01821066
What this trial is testing

Determine If Coadministration Of Tamoxifen Alters The Extent Or Rate Of Palbociclib (PD-0332991) Absorption Or Elimination In Healthy Male Volunteers

Who this might be right for
Healthy
Pfizer 25
Not applicableLooking for participantsNCT06572475
What this trial is testing

USPIO Enhanced MR Imaging in CNS Tumours (UMIC)

Who this might be right for
Vestibular SchwannomaGlioma, Astrocytic
Northern Care Alliance NHS Foundation Trust 17
Not applicableStudy completedNCT06859541
What this trial is testing

Culturally Adapted Play-Based Behavioural Intervention for Autism

Who this might be right for
Autism Spectrum Disorder
Saveetha University 56
Not applicableUnknownNCT02094495
What this trial is testing

Pilot Study About Tamoxifen Therapy for Breast Cancer Patients

Who this might be right for
Breast Cancer
National Cancer Center, Korea 300
Testing effectiveness (Phase 2)Study completedNCT00108069
What this trial is testing

Tamoxifen and Bortezomib to Treat Recurrent Brain Tumors

Who this might be right for
Glioma
National Cancer Institute (NCI) 43
Testing effectiveness (Phase 2)Active Not RecruitingNCT04272801
What this trial is testing

Pre-Operative Window of Adjuvant Endocrine Therapy to Inform RT Decisions in Older Women With Early-Stage Breast Cancer

Who this might be right for
Breast Cancer Female
Shayna Showalter, MD 84
Testing effectiveness (Phase 2)Study completedNCT01257581
What this trial is testing

Safety and Efficacy Study of Creatine and Tamoxifen in Volunteers With Amyotrophic Lateral Sclerosis (ALS)

Who this might be right for
Amyotrophic Lateral Sclerosis
Nazem Atassi 60
Not applicableStudy completedNCT04312347
What this trial is testing

Tamoxifen Dose Adjustment on Indonesian Female ER+ Breast Cancer Patients Based on CYP2D6 Genotype and Endoxifen Levels

Who this might be right for
ER+ Breast Cancer
Nalagenetics Pte Ltd 151
Not applicableStudy completedNCT06874985
What this trial is testing

Effectiveness and Impact of the Lived Experience Cancer Awareness Campaign on Screening Participation

Who this might be right for
Cervical CancersBreast CancerOral Cancer
International Agency for Research on Cancer 1,264
Early research (Phase 1)Study completedNCT00001378
What this trial is testing

A Pilot Trial of Tamoxifen and 4-HPR (4-N-Hydroxyphenyl Retinamide) in Persons at High Risk for Developing Breast Cancer

Who this might be right for
Breast CancerBreast Neoplasms
National Cancer Institute (NCI) 75
Not applicableUnknownNCT00690261
What this trial is testing

The Impact of M1/M2 Tumor Associated Macrophage (TAM) Polarization on Cancer Progression and Prognosis Prediction

Who this might be right for
TumorLung Cancer
National Taiwan University Hospital 100
Testing effectiveness (Phase 2)UnknownNCT00492505
What this trial is testing

Sorafenib, Tamoxifen, and Cisplatin in Treating Patients With High-Risk Stage III Melanoma

Who this might be right for
Melanoma (Skin)
San Diego Pacific Oncology & Hematology Associates 200
Large-scale testing (Phase 3)Looking for participantsNCT06507618
What this trial is testing

Pre-Operative Window of ET to Inform RT Decisions (POWER II)

Who this might be right for
Breast Cancer Female
University of Virginia 354
Large-scale testing (Phase 3)Study completedNCT00003140
What this trial is testing

Letrozole After Tamoxifen in Treating Women With Breast Cancer

Who this might be right for
Breast Cancer
NCIC Clinical Trials Group 5,187
Large-scale testing (Phase 3)Study completedNCT00034125
What this trial is testing

Phase 3 Study of LY353381 Vs Tamoxifen in Women With Locally Advanced or Metastatic Breast Cancer.

Who this might be right for
Breast Neoplasms
Eli Lilly and Company
Testing effectiveness (Phase 2)Looking for participantsNCT07071038
What this trial is testing

Evaluating the Use of a Medication 'Switch' vs Guideline-directed Interventions for Relieving Side Effects of Aromatase Inhibitors Among Breast Cancer Patients

Who this might be right for
Breast CancerAdjuvant TreatmentEarly Stage Breast Cancer
Dartmouth-Hitchcock Medical Center 62
Testing effectiveness (Phase 2)Study completedNCT01231659
What this trial is testing

Safety and Efficacy of RAD001 (Everolimus) in Combination With Letrozole in the Treatment of Postmenopausal Women With Locally Advanced or Metastatic Breast Cancer

Who this might be right for
Postmenopausal WomenLocally Advanced Metastatic Breast CancerMetastatic Breast Cancer
Novartis Pharmaceuticals 72
Large-scale testing (Phase 3)Study completedNCT00152178
What this trial is testing

The Comparative Trial of UFT + TAM With CMF + TAM in Adjuvant Therapy for Breast Cancer (CUBC)

Who this might be right for
Breast Cancer
Taiho Pharmaceutical Co., Ltd. 680
Next Page